Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
432 studies found for:    Open Studies | "Urinary Bladder Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Urinary Bladder Overactive;   Overactive Bladder;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Recruiting Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
6 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Not yet recruiting Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
Conditions: Carcinoma in Situ of Bladder;   Bladder Cancer
Interventions: Drug: Durvalumab;   Procedure: Cystoscopy with Biopsy
9 Not yet recruiting A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided Technique
Condition: Refractory Overactive Bladder
Interventions: Procedure: ultrasound;   Procedure: X-ray
10 Not yet recruiting Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
Conditions: Infiltrating Bladder Urothelial Carcinoma;   Stage II Bladder Urothelial Carcinoma;   Stage III Bladder Urothelial Carcinoma;   Stage IV Bladder Urothelial Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Procedure: Radical Cystectomy;   Biological: Tumor Cell-Derived Vaccine Therapy
11 Recruiting Application-based Perioperative Management of the Radical Cystectomy Patient
Condition: Bladder Cancer
Intervention: Other: LifeScience Technologies application
12 Not yet recruiting Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
Condition: Bladder Cancer
Interventions: Drug: B-701;   Drug: Pembrolizumab
13 Recruiting Intravenous Lidocaine for Cystectomy Procedures
Condition: Invasive Bladder Cancer
Interventions: Procedure: Cystectomy;   Drug: Lidocaine;   Drug: Saline
14 Recruiting A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder
Conditions: Urge Incontinence;   Overactive Bladder
Intervention: Device: Transcutaneous Electrical Nerve Stimulation
15 Not yet recruiting Mirabegron For Erectile Dysfunction
Conditions: Erectile Dysfunction;   Overactive Bladder;   Urinary Incontinence
Intervention: Drug: Mirabegron
16 Recruiting A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia
Condition: Bladder Cancer
Interventions: Procedure: Surgery Radical Cystectomy;   Procedure: Ultrapro mesh
17 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
18 Recruiting Trans-MAPP II Study of Urologic Chronic Pelvin Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis
19 Recruiting A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
Conditions: Urinary Bladder Cancer;   Bladder Tumors;   Transitional Cell Carcinoma of the Bladder;   Malignant Melanoma;   Melanoma;   Skin Cancer;   Carcinoma, Non-Small-Cell Lung;   Lung Cancer
Interventions: Biological: NEO-PV-01;   Biological: Nivolumab;   Other: Adjuvant
20 Not yet recruiting Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Conditions: Solid Neoplasm;   Stage III Pancreatic Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IVA Pancreatic Cancer;   Stage IVB Pancreatic Cancer;   Sarcoma;   Colorectal Cancer;   Head and Neck Cancer;   Cancer of Unknown Primary;   Bladder Cancer;   Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Drug: Palbociclib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years